161 related articles for article (PubMed ID: 31897116)
1. Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis.
Xia HB; Wang HJ; Song SS; Zhang JG; He XL; Hu ZM; Zhang CW; Huang DS; Mou XZ
Oncol Lett; 2020 Jan; 19(1):69-76. PubMed ID: 31897116
[TBL] [Abstract][Full Text] [Related]
2. NMR evidence for oligosaccharide release from the dendritic-cell specific intercellular adhesion molecule 3-grabbing non-integrin-related (CLEC4M) carbohydrate recognition domain at low pH.
Probert F; Mitchell DA; Dixon AM
FEBS J; 2014 Aug; 281(16):3739-50. PubMed ID: 24976257
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.
Wang X; Jiang Y; Yuan M; Chen C; Wang K; Zhang Q; Zuo Y; Ren S
Oncol Lett; 2017 Sep; 14(3):2813-2821. PubMed ID: 28927040
[TBL] [Abstract][Full Text] [Related]
4. Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in lung cancer and significant correlations with brain metastasis and natural killer cells.
Liu X; Zhang H; Su L; Yang P; Xin Z; Zou J; Ren S; Zuo Y
Mol Cell Biochem; 2015 Sep; 407(1-2):151-60. PubMed ID: 26150177
[TBL] [Abstract][Full Text] [Related]
5. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
Soilleux EJ
Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
[TBL] [Abstract][Full Text] [Related]
6. Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin.
Zhang Z; Chen K; Yan L; Yang Z; Zhu Z; Chen C; Zeng J; Wei W; Qi X; Ren S; Zuo Y
Biochem Cell Biol; 2013 Aug; 91(4):214-20. PubMed ID: 23859015
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymorphism in dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related (DC-SIGNR) gene on HIV-1 trans-infection.
Zhu D; Kawana-Tachikawa A; Iwamoto A; Kitamura Y
Biochem Biophys Res Commun; 2010 Mar; 393(4):598-602. PubMed ID: 20152818
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR.
Parent SA; Zhang T; Chrebet G; Clemas JA; Figueroa DJ; Ky B; Blevins RA; Austin CP; Rosen H
Gene; 2002 Jun; 293(1-2):33-46. PubMed ID: 12137941
[TBL] [Abstract][Full Text] [Related]
9. Association of DC-SIGNR Expression in Peripheral Blood Mononuclear Cells with DC-SIGNR Genotypes in HIV-1 Infection.
Chaudhary O; Kumar S; Bala M; Singh J; Hazarika A; Luthra K
Viral Immunol; 2015 Oct; 28(8):472-5. PubMed ID: 26313015
[TBL] [Abstract][Full Text] [Related]
10. Correlation of variable repeat number in the neck regions of DC-SIGN and DC-SIGNR with susceptibility to nasopharyngeal carcinoma in a Chinese population.
Ning S; Yao M; Wu Y; Zhou X; Zhong C; Yan K; Wei Z; Xie Y
Cancer Manag Res; 2018; 10():3193-3198. PubMed ID: 30233235
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.
Jiang Y; Zhang C; Chen K; Chen Z; Sun Z; Zhang Z; Ding D; Ren S; Zuo Y
PLoS One; 2014; 9(12):e114748. PubMed ID: 25504222
[TBL] [Abstract][Full Text] [Related]
12. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis.
Na H; Liu X; Li X; Zhang X; Wang Y; Wang Z; Yuan M; Zhang Y; Ren S; Zuo Y
J Hematol Oncol; 2017 Jan; 10(1):28. PubMed ID: 28109307
[TBL] [Abstract][Full Text] [Related]
13. Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.
Dos Santos Á; Hadjivasiliou A; Ossa F; Lim NK; Turgut A; Taylor ME; Drickamer K
Protein Sci; 2017 Feb; 26(2):306-316. PubMed ID: 27859859
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
15. DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility.
Boily-Larouche G; Zijenah LS; Mbizvo M; Ward BJ; Roger M
Hum Immunol; 2007 Jun; 68(6):523-30. PubMed ID: 17509452
[TBL] [Abstract][Full Text] [Related]
16. Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.
Xia HB; Wang HJ; Fu LQ; Wang SB; Li L; Ru GQ; He XL; Tong XM; Mou XZ; Huang DS
Oncol Lett; 2018 Sep; 16(3):3681-3689. PubMed ID: 30127978
[TBL] [Abstract][Full Text] [Related]
17. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
Song SS; Ying JF; Zhang YN; Pan HY; He XL; Hu ZM; Wang HJ; Dou XB; Mou XZ
Oncol Lett; 2020 Apr; 19(4):3181-3188. PubMed ID: 32256814
[TBL] [Abstract][Full Text] [Related]
18. [DC-SIGNR polymorphisms and its association with HIV-1 infection].
Wang H; Wang C; Feng T; Zhou H; Li L; Wang F; Zhao G; Zhu T; Zhou B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):542-5. PubMed ID: 18841568
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN and DC-SIGNR polymorphic variants in Northern Asian Indians.
Chaudhary O; Bhasin R; Luthra K
Int J Immunogenet; 2008 Dec; 35(6):475-9. PubMed ID: 19046307
[TBL] [Abstract][Full Text] [Related]
20. Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms.
Liu H; Hladik F; Andrus T; Sakchalathorn P; Lentz GM; Fialkow MF; Corey L; McElrath MJ; Zhu T
Eur J Hum Genet; 2005 Jun; 13(6):707-15. PubMed ID: 15812562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
